Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: Novel developments and clinical impact

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 8, 2003, Pages 2385-2392

  Weldhagen, Gerhard F ^a   Poirel, Laurent ^b   Nordmann, Patrice ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEFALORIDINE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFSULODIN; CEFTAZIDIME; CEFTAZIDIME PLUS CLAVULANIC ACID; CEFUROXIME; CHLORHEXIDINE; CLOXACILLIN; DISINFECTANT AGENT; IMIPENEM; MERBROMIN; MEROPENEM; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POVIDONE IODINE; TICARCILLIN; TIMENTIN; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; DRUG HYDROLYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME SUBSTRATE; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; SHORT SURVEY;

ANIMALS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0042769424     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.8.2385-2392.2003     Document Type: Short Survey

References (55)

1. Ambler, R. P., A. F. W. Coulson, J.-M. Frère, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Lévesque, G. Tirabi, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-272.
2. Ben-Mahrez, K., S. Rejiba, C. Belhadj, and O. Belhadj. 1999. β-Lactamase mediated resistance to extended-spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa. Res. Microbiol. 150:403-406.
3. Bert, F., C. Branger, and N. Lambert-Zechowsky. 2002. Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18.
4. Bonnet, R., J. L. Sampaio, C. Chanal, D. Sirot, C. De Champs, J. L. Viellard, R. Labia, and J. Sirot. 2000. A novel class A extended-spectrum β-lactamase (BES-1) in Serratia marcescens in Brazil. Antimicrob. Agents Chemother. 44:3061-3068.
5. Bouthors, A.-T., N. Dagoneau, S. Blanchard, T. Naas, P. Nordmann, V. Jarlier, and W. Sougakoff. 1998. Role of residues 104, 164, 166, 238, 240 in the substrate profile of PER-1 β-lactamase hydrolysing third-generation cephalosporins. Biochem. J. 330:1443-1449.
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
7. Carter, M. W., K. J. Oakton, M. Warner, and D. M. Livermore. 2000. Detection of extended-spectrum β-lactamases in Klebsiellae with the Oxoid combination disk method. J. Clin. Microbiol. 38:4228-4232.
8. Chanawong, A., F. H. M'Zali, J. Heritage, A. Lulitanond, and P. M. Hawkey. 2001. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in gram-negative bacteria isolated in a university hospital in Thailand. J. Antimicrob. Chemother. 48:839-852.
9. Chen, H. Y., M. Yuan, and D. M. Livermore. 1995. Mechanisms of resistance to β-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J. Med. Microbiol. 43:300-309.
10. Claeys, G., G. Verschraegen, T. De Baere, and M. Vaneechoutte. 2000. PER-1 β-lactamase producing Pseudomonas aeruginosa in an intensive care unit. J. Antimicrob. Chemother. 45:924-925.
11. De Champs, C., L. Poirel, R. Bonnet, D. Sirot, C. Chanal, J. Sirot, and P. Nordmann. 2002. Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob. Agents Chemother. 46:3031-3034.
12. Docquier, J.-D., F. Luzzaro, G. Amicosante, A. Toniolo, and G. M. Rossolini. 2001. Multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum serine β-lactamase and VIM-2 metallo-β-lactamase. Emerg. Infect. Dis. 7:910-911.
13. blaTEM-21 gene located on a chromosomal interrupted TnA type transposon. Antimicrob. Agents Chemother. 46:3624-3626.
14. blaGES-1 and a fused product of aac(3)-Ib/aac(6′)-Ib′ gene cassettes in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:638-645.
15. Florijn, A., S. Nijssen, F.-J. Schmitz, J. Verhoef, and A. C. Fluit. 2002. Comparison of E-test and double disk diffusion test for detection of extended spectrum β-lactamases. Eur. J. Clin. Microbiol. Infect. Dis, 21:241-243.
16. Giakkoupi, P., L. S. Tzouvelekis, A. Tsakris, V. Loukova, D. Sofianou, and E. Tzelepi. 2000. IBC-1, a novel integron-associated class A β-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44:2247-2253.
17. Girlich, D., T. Naas, A. Leelaporn, L. Poirel, M. Fennewald, and P. Nordmann. 2002. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-spectrum β-lactamase in Pseudomonas aeruginosa in Thailand. Clin. Infect. Dis. 34:603-611.
18. Girlich, D., L. Poirel, A. Leelaporn, A. Karim, C. Tribuddharat, M. Fennewald, and P. Nordmann. 2001. Molecular epidemiology of the integron-located VEB-1 extended spectrum β-lactamase in nosocomial entero-bacterial isolates in Bangkok, Thailand. J. Clin. Microbiol. 39:175-182.
19. Jarlier, V., M.-H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
20. Langaee, T. Y., L. Gagnon, and A. Huletsky. 2000. Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyper-inducible AmpC B-lactamase expression. Antimicrob. Agents Chemother. 44: 583-589.
21. Lee, S. H., J. Y. Kim, S. H. Shin, S. K. Lee, M. M. Choi, I. Y. Lee, Y. B. Kim, J. Y. Cho, W. Jin, and K. J. Lee. 2001. Restriction fragment length dimorphism-PCR method for the detection of extended-spectrum β-lactamases unrelated to TEM- and SHV-types. FEMS Microbiol. Lett. 200:157-161.
22. Liebert, C. A., R. M. Hall, and A. O. Summers. 1999. Transposon Tn21, flagship of the floating genome. Microbiol. Mol. Biol. Rev. 63:507-522.
23. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
24. Luzzaro, F., E. Mantengoli, M. Perilli, G. Lombardi, V. Orlandi, A. Orsatti, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2001. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase. J. Clin. Microbiol. 39:1865-1870.
25. Marchandin, H., H. Jean-Pierre, C. De Champs, D. Sirot, H. Darbas, P. F. Perigault, and C. Carrière. 2000. Production of a TEM-24 plasmid-mediated extended-spectrum β-lactamase by a clinical isolate of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:213-216.
26. Mavroidi, A., A. Tsakris, E. Tzelepi, S. Pournaras, V. Loukova, and L. S. Tzouvelekis. 2000. Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother. 46:1041-1042.
27. Mavroidi, A., E. Tzelepi, A. Tsakris, V. Miriagou, D. Sofianou, and L. S. Tzouvelekis. 2001. An integron-associated β-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum β-lactamase IBC-1. J. Antimicrob. Chemother. 48:627-630.
28. Medeiros, A. A. 1997. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 24:S19-S45.
29. Mimoz, O., N. Elhelali, S. Léotard, A. Jacolot, F. Laurent, K. Samii, O. Petitjean, and P. Nordmann. 1999. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum β-lactamase producing strain of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 44:91-97.
30. Mugnier, P., P. Dubrous, I. Casin, G. Arlet, and E. Collatz. 1996. A TEM-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:2488-2493.
31. Naas, T., L. Philippon, L. Poirel, E. Ronco, and P. Nordmann. 1999. An SHV-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1281-1284.
32. Naas, T., L. Poirel, A. Karim, and P. Nordmann. 1999. Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 176:411-419.
33. Navarro, F., and E. Miro. 2002. Update on CTX-M-type β-lactamases. Rev. Med. Microbiol. 13:63-73.
34. Nordmann, P., E. Ronco, T. Naas, C. Duport, Y. Michel-Briand, and R. Labia. 1993. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:962-969.
35. Nordmann, P., and T. Naas. 1994. Sequence analysis of PER-1 extended-spectrum β-1actamase from Pseudomonas aeruginosa and comparison with class A β-lactamases. Antimicrob. Agents Chemother. 38:104-114.
36. Paul, G. C., G. Gerbaud, A. Buré, A. M. Philippon, B. Pangon, and P. Courvalin. 1989. TEM-4, a new plasmid-mediated β-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 33:1958-1963.
37. Pellegrino, F. L., L. M. Teixeira, G. Carvalho, S. Aranha Nouer, M. Pinto De Oliveira, J. L. Mello Sampaio, A. D'Aviias Freitas, A. L. Ferreira, L. Amorim, L. W. Riley, and B. M. Moreira. 2002. Occurrence of a multi-drug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J. Clin. Microbiol. 40:2420-2424.
38. Philippon, L. N., T. Naas, A.-T. Bouthors, V. Barakett, and P. Nordmann. 1997. OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41: 2188-2195.
39. Podbielski, A., J. Schönling, B. Melzer, K. Warnatz, and H. G. Leusch. 1991. Molecular characterization of a new plasmid-encoded SHV-type β-lactamase (SHV-2 variant) conferring high level cefotaxime resistance upon Klebsiella pneumoniae. J. Gen. Microbiol. 137:569-578.
40. Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.
41. Poirel, L., T. Naas, M. Guibert, E. B. Chaibi, R. Labia, and P. Nordmann. 1999. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43:573-581.
42. Poirel, L., E. Ronco, T. Naas, and P. Nordmann. 1999. Extended-spectrum β-lactamase TEM-4 in Pseudomonas aeruginosa. Clin. Microbiol. Infect. 5:651-652.
43. Poirel, L., V. O. Rotimi, E. M. Mokaddas, A. Karim, and P. Nordmann. 2001. VEB-1-like extended-spectrum β-lactamases in Pseudomonas aeruginosa, Kuwait. Emerg. Infect. Dis. 7:468-470.
44. Poirel, L., G. F. Weldhagen, C. De Champs, and P. Nordmann. 2002. A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended spectrum β-lactamase GES-2 in South Africa. J. Antimicrob. Chemother. 49:561-565.
45. Poirel, L., G. F. Weldhagen, T. Naas, C. de Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45:2598-2603.
46. Rejiba, S., F. Limam, C. Belhadj, O. Belhadj, and K. Ben-Mahrez. 2002. Biochemical characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa 802. Microb. Drug Resist. 8:9-13.
47. Rice, L. B., J. D. Yao, K. Klimm, G. M. Eliopoulos, and R. C. Moellering. 1991. Efficacy of different β-lactams against an extended-spectrum β-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrob. Agents Chemother. 35:1243-1244.
48. Silva, J., C. Aguilar, G. Ayala, M. A. Estrada, U. Garza-Ramos, R. Lara-Lemus, and L. Ledezma. 2000. TLA-1: a new plasmid-mediated extended-spectrum β-lactamase from Escherichia coli. Antimicrob. Agents Chemother. 44:997-1003.
49. Stokes, H. W., and R. M. Hall. 1989. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3:1669-1683.
50. Stoutenbeek, C. P. 1989. The role of systemic antibiotic prophylaxis in infection prevention in intensive care by SDD. Infection 17:418-421.
51. Tribuddharat, C., and M. Fennewald. 1999. Integron-mediated rifampin resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43: 960-962.
52. Vahaboglu, H., F. Coskunkan, O. Tansel, R. Öztürk, N. Sahin, I. Koksal, B. Kocazeybek, M. Tatman-Ötkun, H. Leblebicioglu, M. A. Ozinel, H. Akalin, S. Kocagoz, and V. Korten. 2001. Clinical importance of extended-spectrum β-lactamase (PER-1-type) producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J. Med. Microbiol. 50:642-645.
53. Vahaboglu, H., S. Dodanli, C. Eroglu, R. Öztürk, G. Soyletir, I. Yildirim, and V. Akan. 1996. Characterization of multiple-antibiotic resistant Salmonella typhimurium strains: molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone. J. Clin. Microbiol. 34:2942-2946.
54. Vahaboglu, H., R. Öztürk, G. Aygun, F. Coskunkan, A. Yaman, A. Kaygusuz, H. Leblebicioglu, I. Balik, K. Aydin, and M. Otkün. 1997. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother. 41:2265-2269.
55. Wolska, M. K., K. Bukowski, and A. Jakubezak. 2001. Occurrence of β-lactamase type ESBL and IBL in Pseudomonas aeruginosa rods. Med. Dosw. Mikrobiol. 53:45-51.